Shen X - Search Results

1

Survival trends and prognostic factors for patients with extramedullary plasmacytoma: A population-based study.

Shen X, Zhang L, Wang J, Chen L, Liu S, Zhang R. Shen X, et al. Front Oncol. 2022 Dec 13;12:1052903. doi: 10.3389/fonc.2022.1052903. eCollection 2022. Front Oncol. 2022. PMID: 36582797 Free PMC article.

2

Long Non-Coding RNA MEG3 Functions as a Competing Endogenous RNA to Regulate HOXA11 Expression by Sponging miR-181a in Multiple Myeloma.

Shen X, Bai H, Zhu H, Yan Q, Yang Y, Yu W, Shi Q, Wang J, Li J, Chen L. Shen X, et al. Cell Physiol Biochem. 2018;49(1):87-100. doi: 10.1159/000492846. Epub 2018 Aug 22. Cell Physiol Biochem. 2018. PMID: 30134227 Free article.

3

TRPV2-induced Ca²⁺-calcineurin-NFAT signaling regulates differentiation of osteoclast in multiple myeloma.

Bai H, Zhu H, Yan Q, Shen X, Lu X, Wang J, Li J, Chen L. Bai H, et al. Among authors: shen x. Cell Commun Signal. 2018 Oct 16;16(1):68. doi: 10.1186/s12964-018-0280-8. Cell Commun Signal. 2018. PMID: 30326911 Free PMC article.

4

Promoter hypermethylation inﬂuences the suppressive role of long non-coding RNA MEG3 in the development of multiple myeloma.

Yu W, Shi Q, Wu C, Shen X, Chen L, Xu J. Yu W, et al. Among authors: shen x. Exp Ther Med. 2020 Jul;20(1):637-645. doi: 10.3892/etm.2020.8723. Epub 2020 May 6. Exp Ther Med. 2020. PMID: 32537021 Free PMC article.

5

Survival trends and prognostic factors in patients with solitary plasmacytoma of bone: A population-based study.

Shen X, Liu S, Wu C, Wang J, Li J, Chen L. Shen X, et al. Cancer Med. 2021 Jan;10(2):462-470. doi: 10.1002/cam4.3533. Epub 2020 Nov 3. Cancer Med. 2021. PMID: 33145987 Free PMC article.

6

Anti-tumor activity of a novel proteasome inhibitor D395 against multiple myeloma and its lower cardiotoxicity compared with carfilzomib.

Shen X, Wu C, Lei M, Yan Q, Zhang H, Zhang L, Wang X, Yang Y, Li J, Zhu Y, Chen L. Shen X, et al. Cell Death Dis. 2021 Apr 30;12(5):429. doi: 10.1038/s41419-021-03701-z. Cell Death Dis. 2021. PMID: 33931582 Free PMC article.

7

Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma.

Zhang L, Shen X, Yu W, Li J, Zhang J, Zhang R, Li J, Chen L. Zhang L, et al. Among authors: shen x. Ann Med. 2021 Dec;53(1):1547-1559. doi: 10.1080/07853890.2021.1970218. Ann Med. 2021. PMID: 34459681 Free PMC article.

8

Baohuoside I Inhibits Tumor Angiogenesis in Multiple Myeloma via the Peroxisome Proliferator-Activated Receptor γ/Vascular Endothelial Growth Factor Signaling Pathway.

Chen Y, Zhang L, Zang X, Shen X, Li J, Chen L. Chen Y, et al. Among authors: shen x. Front Pharmacol. 2022 Mar 7;13:822082. doi: 10.3389/fphar.2022.822082. eCollection 2022. Front Pharmacol. 2022. PMID: 35341213 Free PMC article.

9

Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma.

Zhang L, Zhang R, Wang J, Chen Y, Qiao C, Shi Q, Jin Y, Shen X, Li J, Chen L. Zhang L, et al. Among authors: shen x. Clin Epigenetics. 2022 Jul 23;14(1):93. doi: 10.1186/s13148-022-01314-7. Clin Epigenetics. 2022. PMID: 35870987 Free PMC article.

10

LncRNA MEG3 promotes the sensitivity of bortezomib by inhibiting autophagy in multiple myeloma.

Zang X, Wang J, Xia Y, Li J, Chen L, Gu Y, Shen X. Zang X, et al. Among authors: shen x. Leuk Res. 2022 Dec;123:106967. doi: 10.1016/j.leukres.2022.106967. Epub 2022 Oct 6. Leuk Res. 2022. PMID: 36270092 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,793 results

Search Page

Filters